{"id":906,"date":"2017-08-25T12:10:20","date_gmt":"2017-08-25T11:10:20","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=906"},"modified":"2017-08-25T12:10:20","modified_gmt":"2017-08-25T11:10:20","slug":"duloxetine-depression-chronic-pain-relief-drug-recalled","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled","title":{"rendered":"Depression and chronic pain relief drug, Duloxetine, recalled after failing tests"},"content":{"rendered":"

The drug Duloxetine<\/em>, more commonly known as its brand name Cymbalta<\/em>, is generally used to treat depression, anxiety, and chronic pain. It’s an active ‘serotonin-norepinephrine reuptake inhibitor’, providing pain relief for patients with diabetes or sufferers from chronic or widespread pain.<\/p>\n

The drug is commonly prescribed to people with arthritis and fibromyalgia. However, select batches of the Torrent Dutor Gastro-resistant Capsules have been recalled by the Medicines and Healthcare products Regulatory Agency (MHRA) because “out of specification results for dissolution were obtained during routine stability testing”.
\n
\nManufacturer Torrent Pharma (UK) Ltd are recalling their Dutor Gastro-resistant Hard Capsules<\/em> in 20, 30, 40 and 60mg tablets. The tablets are not to be brushed, chewed, broken or opened as the medication is designed to be swallowed to allow slow release of the contents, but this latest Class 3 recall was initiated amidst concerns that the tablet’s physical integrity may be compromised.<\/p>\n

Those who take the recalled batches of Duloxetine are urged to contact their GP to seek alternative medication<\/strong>. However, Duloxetine has also been under scrutiny for being associated with withdrawal complications, including higher suicide risks, serotonin syndrome, abnormal bleeding, birth defects and even death.<\/p>\n

The importance of safe drug manufacturing<\/h2>\n

The production of medical drugs is no small task as patients rely on them to improve their health and mitigate pain and suffering for all sorts of ailments. Drug manufacturers have a huge responsibility to ensure the products they make are effective whilst remaining safe. Prescribed drugs are usually carefully and expertly tested out to ensure they’re safe for use.<\/p>\n

As such, any problems with the integrity of the medication could lead to the drug being incorrectly administered, which can in turn cause problems for patients.<\/p>\n

Vulnerable patients at risk<\/h3>\n

Particularly potent drugs can significantly alleviate pain, but when used in the wrong way, they can cause serious harm to health. The most common patients who take Duloxetine are people who suffer chronic and widespread pain, and those who suffer from depression and anxiety; as such, we are talking about very vulnerable people indeed.<\/p>\n

Tablets that cannot withstand routine stability testing can cause problems for the patient.<\/p>\n

Claiming compensation<\/h3>\n

If you take prescribed medication and suffer side effects you were not reasonably warned about, you may be eligible to recover compensation for the harm you suffer. Sometimes, your doctor may not even be able to warn you about the adverse risks when the manufacturer do not supply such information, or where they haven’t supplied such information because of a manufacturing error.<\/p>\n

Medical drug manufacturers like Eli Lilly<\/em> who make the branded version of Duloxetine (known as Cymbalta) must ensure extensive testing is carried out before the drug is distributed. Any adverse effects must<\/em> be disclosed and shared with their distributors, medical health providers and the patients. If the adverse risks the drugs carry outweigh the benefits of taking the drug, it should not be made available and pulled off the shelves.<\/p>\n

Whether the problems are caused by a failure to warn you, or by a medical manufacturing defect, you may be eligible for compensation.<\/p>\n","protected":false},"excerpt":{"rendered":"

The drug Duloxetine, more commonly known as its brand name Cymbalta, is generally used to treat depression, anxiety, and chronic pain. It’s an active ‘serotonin-norepinephrine reuptake inhibitor’, providing pain relief for patients with diabetes or sufferers from chronic or widespread pain. The drug is commonly prescribed to people with arthritis and fibromyalgia. However, select batches … Continue reading Depression and chronic pain relief drug, Duloxetine, recalled after failing tests<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1,5],"tags":[20,8],"class_list":["post-906","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest","category-medical","tag-mhra","tag-recalls"],"yoast_head":"\nDuloxetine Depression And Chronic Pain Relief Drug Recalled<\/title>\n<meta name=\"description\" content=\"The drug Duloxetine (also known as Cymbalta) generally used to treat depression, anxiety, and chronic pain has undergone a Class 3 recall by the MHRA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Duloxetine Depression And Chronic Pain Relief Drug Recalled\" \/>\n<meta property=\"og:description\" content=\"The drug Duloxetine (also known as Cymbalta) generally used to treat depression, anxiety, and chronic pain has undergone a Class 3 recall by the MHRA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-25T11:10:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"614\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"headline\":\"Depression and chronic pain relief drug, Duloxetine, recalled after failing tests\",\"datePublished\":\"2017-08-25T11:10:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled\"},\"wordCount\":524,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"keywords\":[\"mhra\",\"recalls\"],\"articleSection\":[\"Latest\",\"Medical\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled\",\"name\":\"Duloxetine Depression And Chronic Pain Relief Drug Recalled\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"datePublished\":\"2017-08-25T11:10:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"description\":\"The drug Duloxetine (also known as Cymbalta) generally used to treat depression, anxiety, and chronic pain has undergone a Class 3 recall by the MHRA.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"width\":750,\"height\":250,\"caption\":\"drugs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/duloxetine-depression-chronic-pain-relief-drug-recalled#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Depression and chronic pain relief drug, Duloxetine, recalled after failing tests\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Duloxetine Depression And Chronic Pain Relief Drug Recalled","description":"The drug Duloxetine (also known as Cymbalta) generally used to treat depression, anxiety, and chronic pain has undergone a Class 3 recall by the MHRA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled","og_locale":"en_GB","og_type":"article","og_title":"Duloxetine Depression And Chronic Pain Relief Drug Recalled","og_description":"The drug Duloxetine (also known as Cymbalta) generally used to treat depression, anxiety, and chronic pain has undergone a Class 3 recall by the MHRA.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled","og_site_name":"Group Action Lawyers","article_published_time":"2017-08-25T11:10:20+00:00","og_image":[{"width":1200,"height":614,"url":"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1","type":"image\/png"}],"author":"Admin","twitter_card":"summary_large_image","twitter_image":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1","twitter_misc":{"Written by":"Admin","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled"},"author":{"name":"Admin","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"headline":"Depression and chronic pain relief drug, Duloxetine, recalled after failing tests","datePublished":"2017-08-25T11:10:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled"},"wordCount":524,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","keywords":["mhra","recalls"],"articleSection":["Latest","Medical"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled","name":"Duloxetine Depression And Chronic Pain Relief Drug Recalled","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","datePublished":"2017-08-25T11:10:20+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"description":"The drug Duloxetine (also known as Cymbalta) generally used to treat depression, anxiety, and chronic pain has undergone a Class 3 recall by the MHRA.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","width":750,"height":250,"caption":"drugs"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Depression and chronic pain relief drug, Duloxetine, recalled after failing tests"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","caption":"Admin"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","jetpack-related-posts":[{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":906,"position":0},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":620,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/does-small-crack-blistering-tablet-packaging-impact-their-effectiveness","url_meta":{"origin":906,"position":1},"title":"Class 3 recall: does the small crack in the blistering of tablet packaging impact their effectiveness?","author":"Admin","date":"19th April 2017","format":false,"excerpt":"The Medicines and Healthcare products Regulatory Agency (MHRA) has recommended recalling instant pain relief tablets due to an issue with some batches. Bayer plc is a pharmaceutical company who manufactured the pain relief tablets in question; Alka-Seltzer Original & Alka-Seltzer XS. Bayer noticed an issue with the blister foil and\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":746,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/teleflex-nasal-drug-atomiser-device-recalled","url_meta":{"origin":906,"position":2},"title":"Teleflex nasal drug atomiser device recalled","author":"Admin","date":"19th June 2017","format":false,"excerpt":"Following a medical device alert back on the 21st April this year, LMA MAD Nasal has recalled their intranasal mucosal atomisation devices after complaints that the device failed to deliver medication properly. The device provides an alternative administration of medication that otherwise may require a needle. Marketed as \"safe, painless\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/teleflex-nasal-atomiser-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/teleflex-nasal-atomiser-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/teleflex-nasal-atomiser-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/teleflex-nasal-atomiser-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":234,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/teva-uk-ltd-has-recalled-progestogen-only-pill-drug","url_meta":{"origin":906,"position":3},"title":"“Progestogen-only Pill Drug Recalls” – Teva UK Ltd has recalled drugs due to impurities showing in their routine testing","author":"Author","date":"17th November 2016","format":false,"excerpt":"Teva UK Limited are one of the latest pharmaceutical manufacturers that have recalled a batch of their drugs. The Nacrez 75 mg film-coated tablets have been recalled due to impurities found as part of their routine testing. The recall is said to be a precautionary measure taken by the company\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":406,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/chewy-calcium-vitamin-d-tablets-being-recalled-for-impurities","url_meta":{"origin":906,"position":4},"title":"Chewy calcium and vitamin-D tablets are being recalled for impurities","author":"Admin","date":"28th December 2016","format":false,"excerpt":"Teva U.K. Limited - a global pharmaceutical company - has recalled a batch of class 2 medicines due to a possible metal contamination. The pharmaceutical company has recently made a precautionary batch recall for a 'small number' of Evacal D3 chewable tablets. The tablets are a calcium-vitamin D supplement used\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1383,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products","url_meta":{"origin":906,"position":5},"title":"MHRA issue “Class 4” drug alert warning for Focus Pharmaceuticals after barcode errors found on 8 medicinal products","author":"Admin","date":"21st February 2018","format":false,"excerpt":"The Medicines and Healthcare Products Regulatory Agency (MHRA) issued a Class 4 (caution in use) warning over eight Focus Pharmaceutical medicinal products after a problem was found with the barcodes. The packaging fault may interfere with prescriptions as the wrong product may be identified when they're scanned. The medicines themselves\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"barcode error alert","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=906"}],"version-history":[{"count":4,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/906\/revisions"}],"predecessor-version":[{"id":917,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/906\/revisions\/917"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/216"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}